Patents Assigned to LANDING BIOTECH, INC.
  • Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
    Patent number: 9018159
    Abstract: The present invention provides pladin (plasma anti-diabetic nucb2 peptide) polypeptide and functional equivalent thereof that are useful for treating diabetes. The present invention provides a method of treating diabetes by administering to a subject nesfatin-1, pladin, or a functional equivalent thereof. The present invention also provides a method of treating diabetes by administering to subject plasmin inhibitors.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: April 28, 2015
    Assignee: Landing Biotech, Inc.
    Inventor: Jian-ning Liu
  • PLASMA ANTI-DIABETIC NUCB2 PEPTIDE (PLADIN) AND USES THEREOF
    Publication number: 20140005105
    Abstract: The present invention provides pladin (plasma anti-diabetic nucb2 peptide) polypeptide and functional equivalent thereof that are useful for treating diabetes. The present invention provides a method of treating diabetes by administering to a subject nesfatin-1, pladin, or a functional equivalent thereof. The present invention also provides a method of treating diabetes by administering to subject plasmin inhibitors.
    Type: Application
    Filed: August 28, 2013
    Publication date: January 2, 2014
    Applicant: Landing Biotech, Inc.
    Inventor: Jian-ning LIU
  • Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
    Patent number: 8541367
    Abstract: The present invention provides pladin (plasma anti-diabetic nucb2 peptide) polypeptide and functional equivalent thereof that are useful for treating diabetes. The present invention provides a method of treating diabetes by administering to a subject nesfatin-1, pladin, or a functional equivalent thereof. The present invention also provides a method of treating diabetes by administering to subject plasmin inhibitors.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: September 24, 2013
    Assignee: Landing Biotech, Inc.
    Inventor: Jian-ning Liu
  • Treating atherosclerosis
    Patent number: 8507646
    Abstract: The present application features methods and compositions for treating patients suffering from atherosclerosis or at risk for developing atherosclerosis. The treatment includes administering to the patient a pharmaceutical composition that includes an agent capable of blocking the interaction between uPA and its receptor uPAR, e.g., an ATF or a fragment thereof, an anti-uPA antibody, a uPAR or a fragment thereof, or an antibody that specifically binds to uPAR.
    Type: Grant
    Filed: February 23, 2007
    Date of Patent: August 13, 2013
    Assignee: Landing Biotech, Inc.
    Inventor: Jian-Ning Liu
  • PLASMA ANTI-DIABETIC NUCB2 PEPTIDE (PLADIN) AND USES THEREOF
    Publication number: 20100235935
    Abstract: The present invention provides pladin (plasma anti-diabetic nucb2 peptide) polypeptide and functional equivalent thereof that are useful for treating diabetes. The present invention provides a method of treating diabetes by administering to a subject nesfatin-1, pladin, or a functional equivalent thereof. The present invention also provides a method of treating diabetes by administering to subject plasmin inhibitors.
    Type: Application
    Filed: March 12, 2010
    Publication date: September 16, 2010
    Applicant: LANDING BIOTECH, INC.
    Inventor: Jian-ning LIU
  • TREATING ATHEROSCLEROSIS
    Publication number: 20100143335
    Abstract: The present application features methods and compositions for treating patients suffering from atherosclerosis or at risk for developing atherosclerosis. The treatment includes administering to the patient a pharmaceutical composition that includes an agent capable of blocking the interaction between uPA and its receptor uPAR, e.g., an ATF or a fragment thereof, an anti-uPA antibody, a uPAR or a fragment thereof, or an antibody that specifically binds to uPAR.
    Type: Application
    Filed: February 23, 2007
    Publication date: June 10, 2010
    Applicant: LANDING BIOTECH, INC.
    Inventor: Jian-ning Liu